UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Clinical cancer research, 2022-11, Vol.28 (21), p.4714-4723

2022

Volltextzugriff (PDF)

Long-Term Follow-Up of the Intergroup Exemestane Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2507-2514

2017

Volltextzugriff (PDF)

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1580-1583

2016

Volltextzugriff (PDF)

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Genome Biology, 2014-09, Vol.15 (9), p.447-447, Article 447

2014

Volltextzugriff (PDF)

Genome sequencing for personalized cancer treatment

Tidsskrift for den Norske Lægeforening, 2012-11, Vol.132 (21), p.2406-2408

2012

Volltextzugriff (PDF)

Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour

European journal of endocrinology, 2012-05, Vol.166 (5), p.941

2012

Volltextzugriff (PDF)

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Volltextzugriff (PDF)

Endocrine effects of aromatase inhibitors

Journal of clinical oncology, 2010-02, Vol.28 (6), p.e101-e102

2010

Volltextzugriff (PDF)

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Clinical cancer research, 2009-06, Vol.15 (12), p.4165-4173

2009

Volltextzugriff (PDF)

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4859-4861

Lønning, Per E

2008

Volltextzugriff (PDF)

GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (14), p.5562-5571

2008

Volltextzugriff (PDF)

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Volltextzugriff (PDF)

Interaction between p53 staining and high-dose chemotherapy in breast cancer

Clinical cancer research, 2006-04, Vol.12 (7 Pt 1), p.2289-2289

2006

Volltextzugriff (PDF)

Antitumor efficacy improved by local delivery of species-specific endostatin

Journal of neurosurgery, 2006, Vol.104 (1), p.118-128

2006

Volltextzugriff (PDF)

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5126-5137

2005

Volltextzugriff (PDF)

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Clinical cancer research, 2005-04, Vol.11 (8), p.2809-2821

2005

Volltextzugriff (PDF)

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement

Clinical cancer research, 2005-01, Vol.11 (2 Pt 2), p.861s-864s

2005

Volltextzugriff (PDF)

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

Clinical cancer research, 2005-01, Vol.11 (2), p.918s-924s

Per E. Lønning

2005

Volltextzugriff (PDF)

Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival

Clinical cancer research, 2005-01, Vol.11 (2), p.951s-958s

2005

Volltextzugriff (PDF)

Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention

Clinical cancer research, 2005-01, Vol.11 (2), p.925s-930s

2005

Volltextzugriff (PDF)

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Clinical cancer research, 2005-01, Vol.11 (2), p.878s-883s

2005

Volltextzugriff (PDF)

Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer

Clinical cancer research, 2004-05, Vol.10 (10), p.3438-3443

2004

Volltextzugriff (PDF)

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

The New England journal of medicine, 2004-03, Vol.350 (11), p.1081-1092

2004

Volltextzugriff (PDF)

TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

Clinical cancer research, 2003-11, Vol.9 (15), p.5582-5588

2003

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionPublisher or Other Site

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)

Sprache

Englisch
(43)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases

Long-Term Follow-Up of the Intergroup Exemestane Study

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Genome sequencing for personalized cancer treatment

Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Endocrine effects of aromatase inhibitors

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Interaction between p53 staining and high-dose chemotherapy in breast cancer

Antitumor efficacy improved by local delivery of species-specific endostatin

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival

Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

Aktive Filter

Suchergebnisse filtern